Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 053, 17584-17592 [2020-06520]
Download as PDF
17584
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
The tracking network collects: (1)
reports of pet food-related illness and
product defects associated with dog
food, cat food, and food for other pets,
which are submitted via the Pet Event
Tracking Network (PETNet); (2) reports
of animal food-related illness and
product defects associated with animal
food for livestock animals, aquaculture
species, and horses (LivestockNet); and
(3) reports about animal food laboratory
samples considered adulterated by State
or FDA regulators (SampleNet).
PETNet and LivestockNet reports
share the following common data
elements, the majority of which are drop
down menu choices: product details
(product name, lot code, product form,
and the manufacturer or distributor/
packer (if known)), the species affected,
number of animals exposed to the
product, number of animals affected,
body systems affected, product
problem/defect, date of onset or the date
product problem was detected, the State
where the incident occurred, the origin
of the information, whether there are
supporting laboratory results, and
contact information for the reporting
member (i.e., name, telephone number
will be captured automatically when
member logs in to the system). For the
LivestockNet report, additional data
elements specific to livestock animals
are captured: product details (indication
of whether the product is a medicated
product, product packaging, and
intended purpose of the product), class
of the animal species affected, and
production loss. For PETNet reports, the
only additional data field is the animal
life stage. The SampleNet reports have
the following data elements, many of
which are drop down menu choices:
product information (product name, lot
code, guarantor information, date and
location of sample collection, and
product description); laboratory
information (sample identification
number, the reason for testing, whether
the food was reported to the Reportable
Food Registry, who performed the
analysis); and results information
(analyte, test method, analytical results,
whether the results contradict a label
claim or guarantee, and whether action
was taken as a result of the sample
analysis).
Description of Respondents:
Voluntary respondents to this collection
of information are Federal, State, and
Territorial regulatory and public health
Agency employees with membership
access to the Animal Feed Network.
In the Federal Register of November
22, 2019 (84 FR 64533), we published a
60-day notice requesting public
comment on the proposed collection of
information. One comment was received
offering general support for the
information collection, but did not
suggest a change to our burden estimate.
At the same time, upon our own
reevaluation we have reduced the
number of respondents to the collection,
which results in an overall reduction of
225 responses and 57 hours annually.
We made this adjustment to better
reflect current use of the tracking
networks. We, therefore, estimate the
burden of the information collection as
follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN
Total annual
responses
Average burden per
response
Total hours
PETNet .............................................................
LivestockNet .....................................................
SampleNet ........................................................
5
5
5
5
5
5
25
25
25
0.25 (15 minutes) .......
0.25 (15 minutes) .......
0.25 (15 minutes) .......
6.25
6.25
6.25
Total ...........................................................
........................
..............................
75
.....................................
18.75
Dated: March 20, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–06537 Filed 3–27–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2004–N–0451]
Food and Drug Administration
Modernization Act of 1997:
Modifications to the List of Recognized
Standards, Recognition List Number:
053
AGENCY:
Food and Drug Administration,
HHS.
lotter on DSKBCFDHB2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Activity
ACTION:
Electronic Submissions
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing a publication containing
modifications the Agency is making to
the list of standards FDA recognizes for
SUMMARY:
VerDate Sep<11>2014
18:05 Mar 27, 2020
use in premarket reviews (FDA
Recognized Consensus Standards). This
publication, entitled ‘‘Modifications to
the List of Recognized Standards,
Recognition List Number: 053’’
(Recognition List Number: 053), will
assist manufacturers who elect to
declare conformity with consensus
standards to meet certain requirements
for medical devices.
DATES: Submit either electronic or
written comments on the notice at any
time. These modifications to the list of
recognized standards are applicable
March 30, 2020.
ADDRESSES: You may submit comments
on the current list of FDA Recognized
Consensus Standards at any time as
follows:
Jkt 250001
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
E:\FR\FM\30MRN1.SGM
30MRN1
lotter on DSKBCFDHB2PROD with NOTICES
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2004–N–0451 for ‘‘Food and Drug
Administration Modernization Act of
1997: Modifications to the List of
Recognized Standards, Recognition List
Number: 053.’’ Received comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday. FDA will consider any
comments received in determining
whether to amend the current listing of
modifications to the list of recognized
standards, Recognition List Number:
053.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
VerDate Sep<11>2014
18:05 Mar 27, 2020
Jkt 250001
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
An electronic copy of Recognition List
Number: 053 is available on the internet
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
Standards/ucm123792.htm. See section
IV for electronic access to the searchable
database for the current list of FDA
recognized consensus standards,
including Recognition List Number: 053
modifications and other standards
related information. Submit written
requests for a single hard copy of the
document entitled ‘‘Modifications to the
List of Recognized Standards,
Recognition List Number: 053’’ to Scott
Colburn, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5606, Silver Spring,
MD 20993, 301–796–6287. Send one
self-addressed adhesive label to assist
that office in processing your request, or
fax your request to 301–847–8144.
FOR FURTHER INFORMATION CONTACT:
Scott Colburn, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5606, Silver Spring,
MD 20993, 301–796–6287,
CDRHStandardsStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Section 204 of the Food and Drug
Administration Modernization Act of
1997 (Pub. L. 105–115) amended section
514 of the Federal Food, Drug, and
Cosmetic Act (FD&C Act) (21 U.S.C.
360d). Amended section 514 of the
FD&C Act allows FDA to recognize
consensus standards developed by
international and national organizations
for use in satisfying portions of device
premarket review submissions or other
requirements.
In the Federal Register of September
14, 2018 (83 FR 46738), FDA announced
the availability of a guidance entitled
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
17585
‘‘Appropriate Use of Voluntary
Consensus Standards in Premarket
Submissions for Medical Devices.’’ The
guidance describes how FDA has
implemented its standards recognition
program and is available at https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents/
appropriate-use-voluntary-consensusstandards-premarket-submissionsmedical-devices. Modifications to the
initial list of recognized standards, as
published in the Federal Register, can
be accessed at https://www.fda.gov/
medical-devices/standards-andconformity-assessment-program/federalregister-documents.
These notices describe the addition,
withdrawal, and revision of certain
standards recognized by FDA. The
Agency maintains a portable document
format (PDF) version of the list of FDA
Recognized Consensus Standards.
Additional information on the Agency’s
Standards and Conformity Assessment
Program is available at https://
www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatoryassistance/standards-and-conformityassessment-program.
II. Modifications to the List of
Recognized Standards, Recognition List
Number: 053
FDA is announcing the addition,
withdrawal, correction, and revision of
certain consensus standards the Agency
is recognizing for use in premarket
submissions and other requirements for
devices. FDA is incorporating these
modifications to the list of FDA
Recognized Consensus Standards in the
Agency’s searchable database. FDA is
using the term ‘‘Recognition List
Number: 053’’ to identify the current
modifications.
In table 1, FDA describes the
following modifications: (1) The
withdrawal of standards and their
replacement by others, if applicable; (2)
the correction of errors made by FDA in
listing previously recognized standards;
and (3) the changes to the
supplementary information sheets of
recognized standards that describe
revisions to the applicability of the
standards.
In section III, FDA lists modifications
the Agency is making that involve new
entries and consensus standards added
as modifications to the list of recognized
standards under Recognition List
Number: 053.
E:\FR\FM\30MRN1.SGM
30MRN1
17586
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS
Old recognition
No.
Replacement
recognition No.
Title of standard 1
Change
A. Anesthesiology
1–47 ................
1–102 ..............
........................
........................
AS 4259–1995 Ancillary devices for expired air resuscitation ................
ISO 80601–2–69 First edition 2014–07–15 Medical electrical equipment—Part 2–69: Particular requirements for basic safety and essential performance of oxygen concentrator equipment.
Withdrawn.
Extent of Recognition.
B. Biocompatibility
2–259 ..............
2–269 .............
2–260 ..............
2–270 .............
2–261 ..............
2–271 .............
USP 42–NF37:2019 <87> Biological Reactivity Test, In Vitro—Direct
Contact Test.
USP 42–NF37:2019 <87> Biological Reactivity Test, In Vitro-Elution
Test.
USP 42–NF37:2019 <88> Biological Reactivity Tests, In Vivo ...............
2–262 ..............
2–272 .............
USP 42–NF37:2019 <151> Pyrogen Test (USP Rabbit Test) ................
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
C. Cardiovascular
3–139 ..............
3–161 .............
ISO 14117 Second edition 2019–09 Active implantable medical devices—Electromagnetic compatibility—EMC test protocols for
implantable cardiac pacemakers, implantable cardioverter
defibrillators and cardiac resynchronization devices.
Withdrawn and replaced with newer
version.
D. Dental/Ear, Nose, and Throat (ENT)
4–186 ..............
4–260 .............
4–212 ..............
4–261 .............
4–229 ..............
4–262 .............
ANSI/ASA S12.2–2019 American National Standard Criteria for Evaluating Room Noise.
ISO 7405 Third edition 2018–10 Corrected version 2018–12 Dentistry—Evaluation of biocompatibility of medical devices used in dentistry.
IEC 80601–2–60 Edition 2.0 2019–06 Medical electrical equipment—
Part 2–60: Particular requirements for the basic safety and essential
performance of dental equipment.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
E. General I (Quality Systems/Risk Management) (QS/RM)
5–103 ..............
5–124 .............
5–40 ................
5–125 .............
ISO 7000 Sixth edition 2019–07 Graphical symbols for use on equipment—Registered symbols.
ISO 14971 Third edition 2019–12 Medical devices—Application of risk
management to medical devices.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
19–13 ..............
........................
19–32 ..............
........................
19–33 ..............
........................
IEC 62133 Edition 2.0 2012–12 Secondary cells and batteries containing alkaline or other non-acid electrolytes—Safety requirements
for portable sealed secondary cells, and for batteries made from
them, for use in portable applications [Including CORRIGENDUM 1
(2013)].
IEC 62133–1 Edition 1.0 2017–02 Secondary cells and batteries containing alkaline or other non-acid electrolytes—Safety requirements
for portable sealed secondary cells, and for batteries made from
them, for use in portable applications—Part 1: Nickel systems.
IEC 62133–2 Edition 2017–02 Secondary cells and batteries containing
alkaline or other non-acid electrolytes—Safety requirements for portable sealed secondary cells, and for batteries made from them, for
use in portable applications—Part 2: Lithium systems.
Transition removed. Recognition restored.
Transition removed.
Transition removed.
lotter on DSKBCFDHB2PROD with NOTICES
G. General Hospital/General Plastic Surgery (GH/GPS)
6–175 ..............
6–424 .............
6–254 ..............
6–425 .............
6–293 ..............
6–426 .............
6–335 ..............
6–427 .............
6–412 ..............
6–428 .............
VerDate Sep<11>2014
18:05 Mar 27, 2020
ASTM D5151–19 Standard Test Method for Detection of Holes in Medical Gloves.
ASTM F2100–19 Standard Specification for Performance of Materials
Used in Medical Face Masks.
ISO 23907–1 First edition 2019–01 Sharps injury protection—Requirements and test methods—Part 1: Single-use sharps containers.
ASTM F2101–19 Standard Test Method for Evaluating the Bacterial
Filtration Efficiency (BFE) of Medical Face Mask Materials, Using a
Biological Aerosol of Staphylococcus aureus.
USP 42–NF37:2019 Sodium Chloride Irrigation ......................................
Jkt 250001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
Withdrawn and replaced with newer
version.
30MRN1
17587
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old recognition
No.
Replacement
recognition No.
Title of standard 1
6–413 ..............
6–429 .............
USP 42–NF37:2019 Sodium Chloride Injection .......................................
6–414 ..............
6–430 .............
USP 42–NF37:2019 Nonabsorbable Surgical Suture ..............................
6–415 ..............
6–431 .............
USP 42–NF37:2019 <881> Tensile Strength ..........................................
6–416 ..............
6–432 .............
USP 42–NF37:2019 <861> Sutures—Diameter ......................................
6–417 ..............
6–433 .............
USP 42–NF37:2019 <871> Sutures—Needle Attachment ......................
6–418 ..............
6–434 .............
USP 42–NF37:2019 Sterile Water for Irrigation ......................................
6–419 ..............
6–435 .............
USP 42–NF37:2019 Heparin Lock Flush Solution ..................................
6–420 ..............
6–436 .............
USP 42–NF37:2019 Absorbable Surgical Suture ....................................
Change
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
H. In Vitro Diagnostics (IVD)
7–226 ..............
7–293 .............
7–281 ..............
7–294 .............
CLSI QMS01, 5th ed. June 2019 (Replaces QMS01–A4) A Quality
Management System Model for Laboratory Services.
CLSI M100, 29th ed. January 2019 (Replaces M100 28th ed.) Performance Standards for Antimicrobial Susceptibility Testing.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
lotter on DSKBCFDHB2PROD with NOTICES
I. Materials
8–68 ................
8–519 .............
8–218 ..............
8–520 .............
8–391 ..............
8–521 .............
8–477 ..............
8–522 .............
8–480 ..............
........................
8–481 ..............
........................
8–484 ..............
........................
8–491 ..............
........................
8–492 ..............
........................
8–494 ..............
........................
8–498 ..............
........................
8–499 ..............
........................
8–500 ..............
........................
8–501 ..............
........................
8–502 ..............
........................
8–505 ..............
........................
8–507 ..............
........................
VerDate Sep<11>2014
18:05 Mar 27, 2020
ISO 13782 Second edition 2019–04 Implants for surgery—Metallic materials—Unalloyed tantalum for surgical implant applications.
F799–19 Standard Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants (UNS R31537, R31538,
R31539).
F2313–18 Standard Specification for Poly(glycolide) and Poly(glycolideco-lactide) Resins for Surgical Implants with Mole Fractions Greater
Than or Equal to 70% Glycolide.
F2129–19a Standard Test Method for Conducting Cyclic
Potentiodynamic Polarization Measurements to Determine the Corrosion Susceptibility of Small Implant Devices.
ASTM F2063–18 Standard Specification for Wrought Nickel-Titanium
Shape Memory Alloys for Medical Devices and Surgical Implants.
ASTM F1314–18 Standard Specification for Wrought Nitrogen
Strengthened 22 Chromium-13 Nickel-5 Manganese-2.5 Molybdenum Stainless Steel Alloy Bar and Wire for Surgical Implants
(UNS S20910).
ASTM F2066–18 Standard Specification for Wrought Titanium-15 Molybdenum Alloy for Surgical Implant Applications (UNS R58150).
ASTM F1088–18 Standard Specification for Beta-Tricalcium Phosphate
for Surgical Implantation.
ISO 5832–9 Third edition 2019–02 Implants for surgery—Metallic materials—Part 9: Wrought high nitrogen stainless steel.
ISO 6474–1 Second edition 2019–03 Implants for surgery—Ceramic
materials—Part 1: Ceramic materials based on high purity alumina.
ASTM F75–18 Standard Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Castings and Casting Alloy for Surgical Implants
(UNS R30075).
ASTM F1580–18 Standard Specification for Titanium and Titanium-6
Aluminum-4 Vanadium Alloy Powders for Coatings of Surgical Implants.
ISO 5832–12 Third edition 2019–02 Implants for surgery—Metallic materials—Part 12: Wrought cobalt-chromium-molybdenum alloy.
ISO 5834–1 Fourth edition 2019–02 Implants for surgery—Ultra-highmolecular-weight polyethylene—Part 1: Powder form.
ASTM F2038–18 Standard Guide for Silicone Elastomers, Gels, and
Foams Used in Medical Applications Part I—Formulations and
Uncured Materials.
ISO 6474–2 Second edition 2019–03 Implants for surgery—Ceramic
materials—Part 2: Composite materials based on a high-purity alumina matrix with zirconia reinforcement.
ASTM F688–19 Standard Specification for Wrought Cobalt-35Nickel20Chromium-10Molybdenum Alloy Plate, Sheet, and Foil for Surgical
Implants (UNS R30035).
Jkt 250001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
Transition period extended.
30MRN1
17588
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old recognition
No.
Replacement
recognition No.
8–508 ..............
........................
8–511 ..............
........................
8–512 ..............
........................
Title of standard 1
Change
ASTM F2579–18 Standard Specification for Amorphous Poly(lactide)
and Poly(lactide-co-glycolide) Resins for Surgical Implants.
ASTM F1925–17 Standard Specification for Semi-Crystalline
Poly(lactide) Polymer and Copolymer Resins for Surgical Implants.
ASTM F2026–17 Standard Specification for Polyetheretherketone
(PEEK) Polymers for Surgical Implant Applications.
Transition period extended.
Withdrawn. Duplicate recognition.
See 8–471.
Withdrawn. Duplicate recognition.
See 8–475.
J. Nanotechnology
No new entries at this time.
K. Neurology
No new entries at this time.
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
9–84 ................
9–123 .............
ISO 8600–3 Second edition 2019–08 Endoscopes—Medical
endoscopes and endotherapy devices—Part 3: Determination of field
of view and direction of view of endoscopes with optics.
Withdrawn and replaced with newer
version.
M. Ophthalmic
No new entries at this time.
N. Orthopedic
11–328 ............
11–360 ...........
ASTM F1378–18 e1 Standard Specification for Shoulder Prostheses ....
Withdrawn and replaced with newer
version.
lotter on DSKBCFDHB2PROD with NOTICES
O. Physical Medicine
16–168 ............
16–207 ...........
16–169 ............
16–208 ...........
16–170 ............
16–209 ...........
16–171 ............
16–210 ...........
16–172 ............
16–211 ...........
16–173 ............
16–212 ...........
16–174 ............
16–213 ...........
16–175 ............
16–214 ...........
16–176 ............
16–215 ...........
VerDate Sep<11>2014
18:05 Mar 27, 2020
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 1: Determination of static stability.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 2: Determination of dynamic stability of electrically powered wheelchairs.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 3: determination of effectiveness of
brakes.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 4 Energy consumption
of electrically powered wheelchairs and scooters for determination of
theoretical distance range.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 5: Determination of dimensions, mass
and maneuvering space.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 6: Determination of
maximum speed of electrically powered wheelchairs.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 7: Method of measurement of seating
and wheel dimensions.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 8: Requirements and test methods for
static, impact and fatigue strengths.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 9: Climatic tests for
electrically powered wheelchairs.
Jkt 250001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
30MRN1
17589
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old recognition
No.
Replacement
recognition No.
Title of standard 1
16–177 ............
16–216 ...........
16–178 ............
16–217 ...........
16–179 ............
16–218 ...........
16–180 ............
16–219 ...........
16–181 ............
16–220 ...........
16–182 ............
16–221 ...........
16–183 ............
16–222 ...........
16–184 ............
16–223 ...........
16–185 ............
16–224 ...........
16–187 ............
16–225 ...........
16–205 ............
........................
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 10: Determination of
obstacle-climbing ability of electrically powered wheelchairs.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 11: Test mannequins.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 13: Determination of coefficient of friction of test surfaces.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 14: Power and control
systems for electrically powered wheelchairs, scooters and add-on
devices—Requirements and test methods.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 15: Requirements for information disclosure, documentation and labeling.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 16: Resistance to ignition of postural
support devices.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 20: Determination of the performance of
stand-up type wheelchairs.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 22: Set-up procedures.
ANSI/RESNA WC–2:2019 American National Standard for Wheelchairs—Volume 2: Additional Requirements for Wheelchairs (including Scooters) with Electrical Systems Section 21: Requirements and
test methods for electromagnetic compatibility of electrically powered
wheelchairs and scooters, and battery chargers.
ANSI/RESNA WC–1:2019 American National Standard for Wheelchairs—Volume 1: Requirements and Test Methods for Wheelchairs
(including Scooters) Section 26: Vocabulary.
ANSI/RESNA W–4:2017 American National Standard for Wheelchairs—Volume 4: Wheelchairs and Transportation.
Change
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn and replaced with a
newer version.
Withdrawn. See 16–226, 16–227,
16–228, and 16–229.
lotter on DSKBCFDHB2PROD with NOTICES
P. Radiology
12–110 ............
12–327 ...........
12–270 ............
12–328 ...........
12–308 ............
12–329 ...........
12–309 ............
........................
12–317 ............
........................
ISO 11551 Third edition 2019–10 Optics and optical instruments—Lasers and laser-related equipment—Test method for absorptance of
optical laser components.
IEC 61223–3–5 Edition 2.0 2019–09 Evaluation and routine testing in
medical imaging departments—Part 3–5: Acceptance tests—Imaging
performance of computed tomography X-ray equipment.
IEC 60601–2–43 Edition 2.2 2019–10 CONSOLIDATED VERSION
Medical electrical equipment—Part 2–43: Particular requirements for
the basic safety and essential performance of X-ray equipment for
interventional procedures.
IEC 60601–2–28 Edition 3.0 2017–06 Medical electrical equipment—
Part 2–28: Particular requirements for the basic safety and essential
performance of X-ray tube assemblies for medical diagnosis.
IEC 60601–2–54 Edition 1.1 2015–04 CONSOLIDATED VERSION
Medical electrical equipment—Part 2–54: Particular requirements for
the basic safety and essential performance of X-ray equipment for
radiography and radioscopy [Including AMENDMENT 2 (2018)].
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Withdrawn and replaced with newer
version.
Transition period extended.
Transition period extended.
Q. Software/Informatics
13–47 ..............
13–110 ...........
13–48 ..............
13–111 ...........
VerDate Sep<11>2014
18:05 Mar 27, 2020
ISO/IEEE 11073–10101 First edition 2004–12–15 Health informatics—
Point-of-care medical device communication—Part 10101: Nomenclature [Including AMENDMENT 1 (2017)].
IEEE Std 11073–10201–2018 Health informatics—Point-of-care medical device communication Part 10201: Domain Information Model.
Jkt 250001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
Withdrawn and replaced with newer
version including amendment.
Withdrawn and replaced with newer
version.
30MRN1
17590
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
TABLE 1—MODIFICATIONS TO THE LIST OF RECOGNIZED STANDARDS—Continued
Old recognition
No.
Replacement
recognition No.
Title of standard 1
Change
R. Sterility
14–325 ............
14–528 ...........
Withdrawn and replaced with newer
version.
14–532 ...........
ISO 11139 First edition 2018–08 Sterilization of health care products—
Vocabulary of terms used in sterilization and related equipment and
process standards.
ISO 18472 Second edition 2018–08 Sterilization of health care products—Biological and chemical indicators—Test equipment.
ISO/ASTM 51276 Fourth edition 2019–08 Practice for use of a
polymethylmethacrylate dosimetry system.
USP 42–NF37:2019 <61> Microbiological Examination of Nonsterile
Products: Microbial Enumeration Tests.
USP 42–NF37:2019 <71> Sterility Tests .................................................
14–354 ............
14–529 ...........
14–382 ............
14–530 ...........
14–520 ............
14–531 ...........
14–521 ............
14–522 ............
14–533 ...........
USP 42–NF37:2019 <85> Bacterial Endotoxins Test .............................
and replaced with newer
14–523 ............
14–534 ...........
14–524 ............
14–535 ...........
14–525 ............
14–536 ...........
14–526 ............
14–537 ...........
USP 42–NF37:2019 <161> Medical Devices-Bacterial Endotoxin and
Pyrogen Tests.
USP 42–NF37:2019 <62> Microbiological Examination of Nonsterile
Products: Tests for Specified Microorganisms.
USP 42–NF37:2019 <55> Biological Indicators—Resistance Performance Tests.
USP 42–NF37:2019 <1229.5> Biological Indicators for Sterilization ......
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
Withdrawn
version.
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
and replaced with newer
S. Tissue Engineering
No new entries at this time.
1 All
standard titles in this table conform to the style requirements of the respective organizations.
III. Listing of New Entries
In table 2, FDA provides the listing of
new entries and consensus standards
added as modifications to the list of
recognized standards under Recognition
List Number: 053. These entries are of
standards not previously recognized by
FDA.
TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS
Title of standard 1
Recognition No.
Reference No. and date
A. Anesthesiology
1–145 ..............
Lung ventilators and related equipment—Vocabulary and semantics .......................
ISO 19223 First edition 2019–07.
B. Biocompatibility
No new entries at this time.
C. Cardiovascular
3–162 ..............
3–163 ..............
Standard Guide for Active Fixation Durability of Endovascular Prostheses ..............
Cardiovascular implants and extracorporeal systems—Centrifugal blood pumps .....
ASTM F3374–19.
ISO 18242 First edition 2016–09–01.
D. Dental/Ear, Nose, and Throat (ENT)
No new entries at this time.
E. General I (Quality Systems/Risk Management) (QS/RM)
.........................
No new entries at this time.
lotter on DSKBCFDHB2PROD with NOTICES
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
No new entries at this time.
G. General Hospital/General Plastic Surgery (GH/GPS)
6–437 ..............
VerDate Sep<11>2014
Sharps injury protection—Requirements and test methods—Part 2: Reusable
sharps containers.
18:05 Mar 27, 2020
Jkt 250001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
ISO 23907–2 First edition 2019–11.
E:\FR\FM\30MRN1.SGM
30MRN1
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
17591
TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS—Continued
Title of standard 1
Recognition No.
6–438 ..............
Reference No. and date
Medical electrical equipment—Part 2–77: Particular requirements for the BASIC
SAFETY and essential performance of ROBOTICALLY ASSISTED SURGICAL
EQUIPMENT.
IEC 80601–2–77 Edition 1.0 2019–07.
H. In Vitro Diagnostics (IVD)
7–295 ..............
Verification of Commercial Microbial Identification and Antimicrobial Susceptibility
Testing Systems.
CLSI M52, 1st ed. August 2015.
I. Materials
8–523 ..............
8–524 ..............
Standard Guide for Using a Force Tester to Evaluate Performance of a Brush Part
Designed to Clean the Internal Channel of a Medical Device.
Standard Guide for Using a Force Tester to Evaluate the Performance of a Brush
Part Designed to Clean the External Surface of a Medical Device.
ASTM F3275–19.
ASTM F3276–19.
J. Nanotechnology
No new entries at this time.
K. Neurology
No new entries at this time.
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
No new entries at this time.
M. Ophthalmic
No new entries at this time.
N. Orthopedic
11–361 ............
11–362 ............
Implants for surgery—Wear of total knee prostheses—Part 5: Durability performance of the patellofemoral joint.
Implants for surgery—Wear of total ankle-joint prostheses—Loading and displacement parameters for wear-testing machines with load or displacement control
and corresponding environmental conditions for test.
ISO 14243–5 First edition 2019–05.
ISO 22622 First edition 2019–07.
O. Physical Medicine
16–226 ............
16–227 ............
16–228 ............
16–229 ............
American National Standard for Wheelchairs—Volume 4: Wheelchairs and Transportation Section 10 Wheelchair containment and occupant retention systems for
use in large accessible transit vehicles: systems for rearward-facing passengers.
American National Standard for Wheelchairs—Volume 4: Wheelchairs and Transportation Section 18: Wheelchair tiedown and occupant restraint systems for use
in motor vehicles.
ANSI/RESNA W–4:2017 American National Standard for Wheelchairs—Volume 4:
Wheelchairs and Transportation Section 19: Wheelchairs used as seats in motor
vehicles.
American National Standard for Wheelchairs—Volume 4: Wheelchairs and Transportation Section 20: Wheelchair seating systems for use in motor vehicles.
ANSI/RESNA WC–4:2017 Section 10.
ANSI/RESNA WC–4:2017 Section 18.
ANSI/RESNA WC–4:2017 Section 19.
ANSI/RESNA WC–4:2017 Section 20.
P. Radiology
No new entries at this time.
Q. Software/Informatics
13–112 ............
Principles for medical device security—Postmarket risk management for device
manufacturers.
AAMI TIR97:2019.
lotter on DSKBCFDHB2PROD with NOTICES
R. Sterility
14–538 ............
Standard Guide for Designing Reusable Medical Devices for Cleanability ...............
ASTM F3357–19.
S. Tissue Engineering
No new entries at this time.
1 All
standard titles in this table conform to the style requirements of the respective organizations.
VerDate Sep<11>2014
21:40 Mar 27, 2020
Jkt 250001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\30MRN1.SGM
30MRN1
17592
Federal Register / Vol. 85, No. 61 / Monday, March 30, 2020 / Notices
IV. List of Recognized Standards
FDA maintains the current list of FDA
Recognized Consensus Standards in a
searchable database that may be
accessed at https://
www.accessdata.fda.gov/scripts/cdrh/
cfdocs/cfStandards/search.cfm. Such
standards are those that FDA has
recognized by notice published in the
Federal Register or that FDA has
decided to recognize but for which
recognition is pending (because a
periodic notice has not yet appeared in
the Federal Register). FDA will
announce additional modifications and
revisions to the list of recognized
consensus standards, as needed, in the
Federal Register once a year, or more
often if necessary.
V. Recommendation of Standards for
Recognition by FDA
Any person may recommend
consensus standards as candidates for
recognition under section 514 of the
FD&C Act by submitting such
recommendations, with reasons for the
recommendation, to
CDRHStandardsStaff@fda.hhs.gov. To
be considered, such recommendations
should contain, at a minimum, the
information listed on FDA’s website,
which is specifically available at https://
www.fda.gov/medical-devices/
standards-and-conformity-assessmentprogram/recognition-standard.
Dated: March 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–06520 Filed 3–27–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Designation of Scarce
Materials or Threatened Materials
Subject to COVID–19 Hoarding
Prevention Measures
Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) announces the
issuance of a Notice under Executive
Order 13910 (Executive order) and
section 102 of the Defense Production
Act of 1950 (the Act), as amended,
designating health and medical
resources necessary to respond to the
spread of Coronavirus Disease 2019
(COVID–19) that are scarce or the
supply of which would be threatened by
excessive accumulation. These
designated materials are subject to the
hoarding prevention measures
lotter on DSKBCFDHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:05 Mar 27, 2020
Jkt 250001
authorized under the Executive order
and the Act. The Notice was issued on
March 25, 2020.
DATES: This action took effect March 25,
2020.
FOR FURTHER INFORMATION CONTACT:
Bryan Shuy: 202–703–8610;
Bryan.Shuy@hhs.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2020, and in response to the spread
of COVID–19, President Trump signed
Executive Order 13910 (Executive order)
to prevent hoarding of health and
medical resources necessary to respond
to the spread of COVID–19 within the
United States. As provided in the
Executive order, it is the policy of the
United States that health and medical
resources needed to respond to the
spread of COVID–19, such as personal
protective equipment and sanitizing and
disinfecting products, are appropriately
distributed. This policy furthers the goal
of protecting the Nation’s healthcare
systems from undue strain.
Through the Executive order, the
President delegated, to the Secretary of
Health and Human Services (the
Secretary), his authority under section
102 of the Defense Production Act of
1950, 50 U.S.C. 4512, as amended (the
Act), to prevent hoarding of health and
medical resources necessary to respond
to the spread of COVID–19 within the
United States, and his authority to
implement the Act in subsection III of
chapter 55 of title 50, United States
Code (50 U.S.C. 4554, 4555, 4556, and
4660). Under this delegation and the
Act, the Secretary may designate such
resources as scarce materials or
materials the supply of which would be
threatened by such accumulation
(threatened materials). The Secretary
may also prescribe conditions with
respect to accumulation of such
materials in excess of the reasonable
demands of business, personal, or home
consumption. The Act prohibits any
person from accumulating designated
materials (1) in excess of the reasonable
demands of business, personal, or home
consumption, or (2) for the purpose of
resale at prices in excess of prevailing
market prices.
HHS is issuing this Notice designating
scarce materials or threatened materials
that are subject to the hoarding
prevention measures authorized under
the Executive order and the Act. Under
50 U.S.C. 4552(13), the term ‘‘materials’’
includes any raw materials (including
minerals, metals, and advanced
processed materials), commodities,
articles, components (including critical
components), products, and items of
supply; and any technical information
or services ancillary to the use of any
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
such materials, commodities, articles,
components, products, or items. For
purposes of this Notice, the term ‘‘scarce
materials or threatened materials’’
means health or medical resources, or
any of their essential components,
determined by the Secretary to be
needed to respond to the spread of
COVID–19 and which are, or are likely
to be, in short supply or the supply of
which would be threatened by hoarding.
Designated scarce materials or
threatened materials are subject to
periodic review by the Secretary.
This designation is not a ‘‘regulation’’
under the Act. See 50 U.S.C. 4559. To
the extent that it were, the Secretary
finds that, in light of the current global
pandemic, urgent and compelling
circumstances make compliance with
public comment requirements
impracticable.
See id. This designation shall terminate
after 120 days from the date of
publication, unless superseded by a
subsequent notice.
A copy of the Notice is provided
below and also can be found on HHS’s
website.
NOTICE OF DESIGNATION OF
SCARCE MATERIALS OR
THREATENED MATERIALS
Health or medical resources, or any of
their essential components, determined
by the Secretary of HHS to be needed to
respond to the spread of COVID–19 and
which are, or are likely to be, in short
supply (scarce materials) or the supply
of which would be threatened by
hoarding (threatened materials).
Designated scarce materials or
threatened materials are subject to
periodic review by the Secretary.
The following materials are
designated pursuant to section 102 of
the Defense Production Act (50 U.S.C.
4512) and Executive Order 13190 of
March 23, 2020 (Preventing Hoarding of
Health and Medical Resources to
Respond to the Spread of COVID–19) as
scarce materials or threatened materials:
1. N–95 Filtering Facepiece Respirators,
including devices that are
disposable half-face-piece nonpowered air-purifying particulate
respirators intended for use to cover
the nose and mouth of the wearer
to help reduce wearer exposure to
pathogenic biological airborne
particulates
2. Other Filtering Facepiece Respirators
(e.g., those designated as N99,
N100, R95, R99, R100, or P95, P99,
P100), including single-use,
disposable half-mask respiratory
protective devices that cover the
user’s airway (nose and mouth) and
E:\FR\FM\30MRN1.SGM
30MRN1
Agencies
[Federal Register Volume 85, Number 61 (Monday, March 30, 2020)]
[Notices]
[Pages 17584-17592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06520]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2004-N-0451]
Food and Drug Administration Modernization Act of 1997:
Modifications to the List of Recognized Standards, Recognition List
Number: 053
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
a publication containing modifications the Agency is making to the list
of standards FDA recognizes for use in premarket reviews (FDA
Recognized Consensus Standards). This publication, entitled
``Modifications to the List of Recognized Standards, Recognition List
Number: 053'' (Recognition List Number: 053), will assist manufacturers
who elect to declare conformity with consensus standards to meet
certain requirements for medical devices.
DATES: Submit either electronic or written comments on the notice at
any time. These modifications to the list of recognized standards are
applicable March 30, 2020.
ADDRESSES: You may submit comments on the current list of FDA
Recognized Consensus Standards at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
[[Page 17585]]
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2004-N-0451 for ``Food and Drug Administration Modernization Act of
1997: Modifications to the List of Recognized Standards, Recognition
List Number: 053.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at https://www.regulations.gov or at the Dockets Management
Staff between 9 a.m. and 4 p.m., Monday through Friday. FDA will
consider any comments received in determining whether to amend the
current listing of modifications to the list of recognized standards,
Recognition List Number: 053.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
An electronic copy of Recognition List Number: 053 is available on
the internet at https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Standards/ucm123792.htm. See section IV for
electronic access to the searchable database for the current list of
FDA recognized consensus standards, including Recognition List Number:
053 modifications and other standards related information. Submit
written requests for a single hard copy of the document entitled
``Modifications to the List of Recognized Standards, Recognition List
Number: 053'' to Scott Colburn, Center for Devices and Radiological
Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
66, Rm. 5606, Silver Spring, MD 20993, 301-796-6287. Send one self-
addressed adhesive label to assist that office in processing your
request, or fax your request to 301-847-8144.
FOR FURTHER INFORMATION CONTACT: Scott Colburn, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5606, Silver Spring, MD 20993, 301-796-6287,
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background
Section 204 of the Food and Drug Administration Modernization Act
of 1997 (Pub. L. 105-115) amended section 514 of the Federal Food,
Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360d). Amended section 514
of the FD&C Act allows FDA to recognize consensus standards developed
by international and national organizations for use in satisfying
portions of device premarket review submissions or other requirements.
In the Federal Register of September 14, 2018 (83 FR 46738), FDA
announced the availability of a guidance entitled ``Appropriate Use of
Voluntary Consensus Standards in Premarket Submissions for Medical
Devices.'' The guidance describes how FDA has implemented its standards
recognition program and is available at https://www.fda.gov/regulatory-information/search-fda-guidance-documents/appropriate-use-voluntary-consensus-standards-premarket-submissions-medical-devices.
Modifications to the initial list of recognized standards, as published
in the Federal Register, can be accessed at https://www.fda.gov/medical-devices/standards-and-conformity-assessment-program/federal-register-documents.
These notices describe the addition, withdrawal, and revision of
certain standards recognized by FDA. The Agency maintains a portable
document format (PDF) version of the list of FDA Recognized Consensus
Standards. Additional information on the Agency's Standards and
Conformity Assessment Program is available at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/standards-and-conformity-assessment-program.
II. Modifications to the List of Recognized Standards, Recognition List
Number: 053
FDA is announcing the addition, withdrawal, correction, and
revision of certain consensus standards the Agency is recognizing for
use in premarket submissions and other requirements for devices. FDA is
incorporating these modifications to the list of FDA Recognized
Consensus Standards in the Agency's searchable database. FDA is using
the term ``Recognition List Number: 053'' to identify the current
modifications.
In table 1, FDA describes the following modifications: (1) The
withdrawal of standards and their replacement by others, if applicable;
(2) the correction of errors made by FDA in listing previously
recognized standards; and (3) the changes to the supplementary
information sheets of recognized standards that describe revisions to
the applicability of the standards.
In section III, FDA lists modifications the Agency is making that
involve new entries and consensus standards added as modifications to
the list of recognized standards under Recognition List Number: 053.
[[Page 17586]]
Table 1--Modifications to the List of Recognized Standards
----------------------------------------------------------------------------------------------------------------
Old recognition No. Replacement recognition No. Title of standard \1\ Change
----------------------------------------------------------------------------------------------------------------
A. Anesthesiology
----------------------------------------------------------------------------------------------------------------
1-47....................... ........................... AS 4259-1995 Ancillary Withdrawn.
devices for expired air
resuscitation.
1-102...................... ........................... ISO 80601-2-69 First edition Extent of Recognition.
2014-07-15 Medical
electrical equipment--Part 2-
69: Particular requirements
for basic safety and
essential performance of
oxygen concentrator
equipment.
----------------------------------------------------------------------------------------------------------------
B. Biocompatibility
----------------------------------------------------------------------------------------------------------------
2-259...................... 2-269...................... USP 42-NF37:2019 <87> Withdrawn and replaced
Biological Reactivity Test, with newer version.
In Vitro--Direct Contact
Test.
2-260...................... 2-270...................... USP 42-NF37:2019 <87> Withdrawn and replaced
Biological Reactivity Test, with newer version.
In Vitro-Elution Test.
2-261...................... 2-271...................... USP 42-NF37:2019 <88> Withdrawn and replaced
Biological Reactivity Tests, with newer version.
In Vivo.
2-262...................... 2-272...................... USP 42-NF37:2019 <151> Withdrawn and replaced
Pyrogen Test (USP Rabbit with newer version.
Test).
----------------------------------------------------------------------------------------------------------------
C. Cardiovascular
----------------------------------------------------------------------------------------------------------------
3-139...................... 3-161...................... ISO 14117 Second edition 2019- Withdrawn and replaced
09 Active implantable with newer version.
medical devices--
Electromagnetic
compatibility--EMC test
protocols for implantable
cardiac pacemakers,
implantable cardioverter
defibrillators and cardiac
resynchronization devices.
----------------------------------------------------------------------------------------------------------------
D. Dental/Ear, Nose, and Throat (ENT)
----------------------------------------------------------------------------------------------------------------
4-186...................... 4-260...................... ANSI/ASA S12.2-2019 American Withdrawn and replaced
National Standard Criteria with newer version.
for Evaluating Room Noise.
4-212...................... 4-261...................... ISO 7405 Third edition 2018- Withdrawn and replaced
10 Corrected version 2018-12 with newer version.
Dentistry--Evaluation of
biocompatibility of medical
devices used in dentistry.
4-229...................... 4-262...................... IEC 80601-2-60 Edition 2.0 Withdrawn and replaced
2019-06 Medical electrical with newer version.
equipment--Part 2-60:
Particular requirements for
the basic safety and
essential performance of
dental equipment.
----------------------------------------------------------------------------------------------------------------
E. General I (Quality Systems/Risk Management) (QS/RM)
----------------------------------------------------------------------------------------------------------------
5-103...................... 5-124...................... ISO 7000 Sixth edition 2019- Withdrawn and replaced
07 Graphical symbols for use with newer version.
on equipment--Registered
symbols.
5-40....................... 5-125...................... ISO 14971 Third edition 2019- Withdrawn and replaced
12 Medical devices-- with newer version.
Application of risk
management to medical
devices.
----------------------------------------------------------------------------------------------------------------
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
----------------------------------------------------------------------------------------------------------------
19-13...................... ........................... IEC 62133 Edition 2.0 2012-12 Transition removed.
Secondary cells and Recognition restored.
batteries containing
alkaline or other non-acid
electrolytes--Safety
requirements for portable
sealed secondary cells, and
for batteries made from
them, for use in portable
applications [Including
CORRIGENDUM 1 (2013)].
19-32...................... ........................... IEC 62133-1 Edition 1.0 2017- Transition removed.
02 Secondary cells and
batteries containing
alkaline or other non-acid
electrolytes--Safety
requirements for portable
sealed secondary cells, and
for batteries made from
them, for use in portable
applications--Part 1: Nickel
systems.
19-33...................... ........................... IEC 62133-2 Edition 2017-02 Transition removed.
Secondary cells and
batteries containing
alkaline or other non-acid
electrolytes--Safety
requirements for portable
sealed secondary cells, and
for batteries made from
them, for use in portable
applications--Part 2:
Lithium systems.
----------------------------------------------------------------------------------------------------------------
G. General Hospital/General Plastic Surgery (GH/GPS)
----------------------------------------------------------------------------------------------------------------
6-175...................... 6-424...................... ASTM D5151-19 Standard Test Withdrawn and replaced
Method for Detection of with newer version.
Holes in Medical Gloves.
6-254...................... 6-425...................... ASTM F2100-19 Standard Withdrawn and replaced
Specification for with newer version.
Performance of Materials
Used in Medical Face Masks.
6-293...................... 6-426...................... ISO 23907-1 First edition Withdrawn and replaced
2019-01 Sharps injury with newer version.
protection--Requirements and
test methods--Part 1: Single-
use sharps containers.
6-335...................... 6-427...................... ASTM F2101-19 Standard Test Withdrawn and replaced
Method for Evaluating the with newer version.
Bacterial Filtration
Efficiency (BFE) of Medical
Face Mask Materials, Using a
Biological Aerosol of
Staphylococcus aureus.
6-412...................... 6-428...................... USP 42-NF37:2019 Sodium Withdrawn and replaced
Chloride Irrigation. with newer version.
[[Page 17587]]
6-413...................... 6-429...................... USP 42-NF37:2019 Sodium Withdrawn and replaced
Chloride Injection. with newer version.
6-414...................... 6-430...................... USP 42-NF37:2019 Withdrawn and replaced
Nonabsorbable Surgical with newer version.
Suture.
6-415...................... 6-431...................... USP 42-NF37:2019 <881> Withdrawn and replaced
Tensile Strength. with newer version.
6-416...................... 6-432...................... USP 42-NF37:2019 <861> Withdrawn and replaced
Sutures--Diameter. with newer version.
6-417...................... 6-433...................... USP 42-NF37:2019 <871> Withdrawn and replaced
Sutures--Needle Attachment. with newer version.
6-418...................... 6-434...................... USP 42-NF37:2019 Sterile Withdrawn and replaced
Water for Irrigation. with newer version.
6-419...................... 6-435...................... USP 42-NF37:2019 Heparin Lock Withdrawn and replaced
Flush Solution. with newer version.
6-420...................... 6-436...................... USP 42-NF37:2019 Absorbable Withdrawn and replaced
Surgical Suture. with newer version.
----------------------------------------------------------------------------------------------------------------
H. In Vitro Diagnostics (IVD)
----------------------------------------------------------------------------------------------------------------
7-226...................... 7-293...................... CLSI QMS01, 5th ed. June 2019 Withdrawn and replaced
(Replaces QMS01-A4) A with newer version.
Quality Management System
Model for Laboratory
Services.
7-281...................... 7-294...................... CLSI M100, 29th ed. January Withdrawn and replaced
2019 (Replaces M100 28th with newer version.
ed.) Performance Standards
for Antimicrobial
Susceptibility Testing.
----------------------------------------------------------------------------------------------------------------
I. Materials
----------------------------------------------------------------------------------------------------------------
8-68....................... 8-519...................... ISO 13782 Second edition 2019- Withdrawn and replaced
04 Implants for surgery-- with newer version.
Metallic materials--
Unalloyed tantalum for
surgical implant
applications.
8-218...................... 8-520...................... F799-19 Standard Withdrawn and replaced
Specification for Cobalt-28 with newer version.
Chromium-6 Molybdenum Alloy
Forgings for Surgical
Implants (UNS R31537,
R31538, R31539).
8-391...................... 8-521...................... F2313-18 Standard Withdrawn and replaced
Specification for with newer version.
Poly(glycolide) and
Poly(glycolide-co-lactide)
Resins for Surgical Implants
with Mole Fractions Greater
Than or Equal to 70%
Glycolide.
8-477...................... 8-522...................... F2129-19a Standard Test Withdrawn and replaced
Method for Conducting Cyclic with newer version.
Potentiodynamic Polarization
Measurements to Determine
the Corrosion Susceptibility
of Small Implant Devices.
8-480...................... ........................... ASTM F2063-18 Standard Transition period
Specification for Wrought extended.
Nickel-Titanium Shape Memory
Alloys for Medical Devices
and Surgical Implants.
8-481...................... ........................... ASTM F1314-18 Standard Transition period
Specification for Wrought extended.
Nitrogen Strengthened 22
Chromium-13 Nickel-5
Manganese-2.5 Molybdenum
Stainless Steel Alloy Bar
and Wire for Surgical
Implants (UNS S20910).
8-484...................... ........................... ASTM F2066-18 Standard Transition period
Specification for Wrought extended.
Titanium-15 Molybdenum Alloy
for Surgical Implant
Applications (UNS R58150).
8-491...................... ........................... ASTM F1088-18 Standard Transition period
Specification for Beta- extended.
Tricalcium Phosphate for
Surgical Implantation.
8-492...................... ........................... ISO 5832-9 Third edition 2019- Transition period
02 Implants for surgery-- extended.
Metallic materials--Part 9:
Wrought high nitrogen
stainless steel.
8-494...................... ........................... ISO 6474-1 Second edition Transition period
2019-03 Implants for extended.
surgery--Ceramic materials--
Part 1: Ceramic materials
based on high purity alumina.
8-498...................... ........................... ASTM F75-18 Standard Transition period
Specification for Cobalt-28 extended.
Chromium-6 Molybdenum Alloy
Castings and Casting Alloy
for Surgical Implants (UNS
R30075).
8-499...................... ........................... ASTM F1580-18 Standard Transition period
Specification for Titanium extended.
and Titanium-6 Aluminum-4
Vanadium Alloy Powders for
Coatings of Surgical
Implants.
8-500...................... ........................... ISO 5832-12 Third edition Transition period
2019-02 Implants for extended.
surgery--Metallic materials--
Part 12: Wrought cobalt-
chromium-molybdenum alloy.
8-501...................... ........................... ISO 5834-1 Fourth edition Transition period
2019-02 Implants for extended.
surgery--Ultra-high-
molecular-weight
polyethylene--Part 1: Powder
form.
8-502...................... ........................... ASTM F2038-18 Standard Guide Transition period
for Silicone Elastomers, extended.
Gels, and Foams Used in
Medical Applications Part I--
Formulations and Uncured
Materials.
8-505...................... ........................... ISO 6474-2 Second edition Transition period
2019-03 Implants for extended.
surgery--Ceramic materials--
Part 2: Composite materials
based on a high-purity
alumina matrix with zirconia
reinforcement.
8-507...................... ........................... ASTM F688-19 Standard Transition period
Specification for Wrought extended.
Cobalt-35Nickel-20Chromium-
10Molybdenum Alloy Plate,
Sheet, and Foil for Surgical
Implants (UNS R30035).
[[Page 17588]]
8-508...................... ........................... ASTM F2579-18 Standard Transition period
Specification for Amorphous extended.
Poly(lactide) and
Poly(lactide-co-glycolide)
Resins for Surgical Implants.
8-511...................... ........................... ASTM F1925-17 Standard Withdrawn. Duplicate
Specification for Semi- recognition. See 8-
Crystalline Poly(lactide) 471.
Polymer and Copolymer Resins
for Surgical Implants.
8-512...................... ........................... ASTM F2026-17 Standard Withdrawn. Duplicate
Specification for recognition. See 8-
Polyetheretherketone (PEEK) 475.
Polymers for Surgical
Implant Applications.
----------------------------------------------------------------------------------------------------------------
J. Nanotechnology
----------------------------------------------------------------------------------------------------------------
No new entries at this time..
----------------------------------------------------------------------------------------------------------------
K. Neurology
----------------------------------------------------------------------------------------------------------------
No new entries at this time..
----------------------------------------------------------------------------------------------------------------
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
----------------------------------------------------------------------------------------------------------------
9-84....................... 9-123...................... ISO 8600-3 Second edition Withdrawn and replaced
2019-08 Endoscopes--Medical with newer version.
endoscopes and endotherapy
devices--Part 3:
Determination of field of
view and direction of view
of endoscopes with optics.
----------------------------------------------------------------------------------------------------------------
M. Ophthalmic
----------------------------------------------------------------------------------------------------------------
No new entries at this time..
----------------------------------------------------------------------------------------------------------------
N. Orthopedic
----------------------------------------------------------------------------------------------------------------
11-328..................... 11-360..................... ASTM F1378-18 [egr]1 Standard Withdrawn and replaced
Specification for Shoulder with newer version.
Prostheses.
----------------------------------------------------------------------------------------------------------------
O. Physical Medicine
----------------------------------------------------------------------------------------------------------------
16-168..................... 16-207..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
1: Determination of static
stability.
16-169..................... 16-208..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 2:
Determination of dynamic
stability of electrically
powered wheelchairs.
16-170..................... 16-209..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
3: determination of
effectiveness of brakes.
16-171..................... 16-210..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 4 Energy
consumption of electrically
powered wheelchairs and
scooters for determination
of theoretical distance
range.
16-172..................... 16-211..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
5: Determination of
dimensions, mass and
maneuvering space.
16-173..................... 16-212..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 6:
Determination of maximum
speed of electrically
powered wheelchairs.
16-174..................... 16-213..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
7: Method of measurement of
seating and wheel dimensions.
16-175..................... 16-214..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
8: Requirements and test
methods for static, impact
and fatigue strengths.
16-176..................... 16-215..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 9: Climatic
tests for electrically
powered wheelchairs.
[[Page 17589]]
16-177..................... 16-216..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 10:
Determination of obstacle-
climbing ability of
electrically powered
wheelchairs.
16-178..................... 16-217..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
11: Test mannequins.
16-179..................... 16-218..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
13: Determination of
coefficient of friction of
test surfaces.
16-180..................... 16-219..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 14: Power
and control systems for
electrically powered
wheelchairs, scooters and
add-on devices--Requirements
and test methods.
16-181..................... 16-220..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
15: Requirements for
information disclosure,
documentation and labeling.
16-182..................... 16-221..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
16: Resistance to ignition
of postural support devices.
16-183..................... 16-222..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
20: Determination of the
performance of stand-up type
wheelchairs.
16-184..................... 16-223..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
22: Set-up procedures.
16-185..................... 16-224..................... ANSI/RESNA WC-2:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 2:
Additional Requirements for
Wheelchairs (including
Scooters) with Electrical
Systems Section 21:
Requirements and test
methods for electromagnetic
compatibility of
electrically powered
wheelchairs and scooters,
and battery chargers.
16-187..................... 16-225..................... ANSI/RESNA WC-1:2019 American Withdrawn and replaced
National Standard for with a newer version.
Wheelchairs--Volume 1:
Requirements and Test
Methods for Wheelchairs
(including Scooters) Section
26: Vocabulary.
16-205..................... ........................... ANSI/RESNA W-4:2017 American Withdrawn. See 16-226,
National Standard for 16-227, 16-228, and 16-
Wheelchairs--Volume 4: 229.
Wheelchairs and
Transportation.
----------------------------------------------------------------------------------------------------------------
P. Radiology
----------------------------------------------------------------------------------------------------------------
12-110..................... 12-327..................... ISO 11551 Third edition 2019- Withdrawn and replaced
10 Optics and optical with newer version.
instruments--Lasers and
laser-related equipment--
Test method for absorptance
of optical laser components.
12-270..................... 12-328..................... IEC 61223-3-5 Edition 2.0 Withdrawn and replaced
2019-09 Evaluation and with newer version.
routine testing in medical
imaging departments--Part 3-
5: Acceptance tests--Imaging
performance of computed
tomography X-ray equipment.
12-308..................... 12-329..................... IEC 60601-2-43 Edition 2.2 Withdrawn and replaced
2019-10 CONSOLIDATED VERSION with newer version.
Medical electrical
equipment--Part 2-43:
Particular requirements for
the basic safety and
essential performance of X-
ray equipment for
interventional procedures.
12-309..................... ........................... IEC 60601-2-28 Edition 3.0 Transition period
2017-06 Medical electrical extended.
equipment--Part 2-28:
Particular requirements for
the basic safety and
essential performance of X-
ray tube assemblies for
medical diagnosis.
12-317..................... ........................... IEC 60601-2-54 Edition 1.1 Transition period
2015-04 CONSOLIDATED VERSION extended.
Medical electrical
equipment--Part 2-54:
Particular requirements for
the basic safety and
essential performance of X-
ray equipment for
radiography and radioscopy
[Including AMENDMENT 2
(2018)].
----------------------------------------------------------------------------------------------------------------
Q. Software/Informatics
----------------------------------------------------------------------------------------------------------------
13-47...................... 13-110..................... ISO/IEEE 11073-10101 First Withdrawn and replaced
edition 2004-12-15 Health with newer version
informatics--Point-of-care including amendment.
medical device
communication--Part 10101:
Nomenclature [Including
AMENDMENT 1 (2017)].
13-48...................... 13-111..................... IEEE Std 11073-10201-2018 Withdrawn and replaced
Health informatics--Point-of- with newer version.
care medical device
communication Part 10201:
Domain Information Model.
----------------------------------------------------------------------------------------------------------------
[[Page 17590]]
R. Sterility
----------------------------------------------------------------------------------------------------------------
14-325..................... 14-528..................... ISO 11139 First edition 2018- Withdrawn and replaced
08 Sterilization of health with newer version.
care products--Vocabulary of
terms used in sterilization
and related equipment and
process standards.
14-354..................... 14-529..................... ISO 18472 Second edition 2018- Withdrawn and replaced
08 Sterilization of health with newer version.
care products--Biological
and chemical indicators--
Test equipment.
14-382..................... 14-530..................... ISO/ASTM 51276 Fourth edition Withdrawn and replaced
2019-08 Practice for use of with newer version.
a polymethylmethacrylate
dosimetry system.
14-520..................... 14-531..................... USP 42-NF37:2019 <61> Withdrawn and replaced
Microbiological Examination with newer version.
of Nonsterile Products:
Microbial Enumeration Tests.
14-521..................... 14-532..................... USP 42-NF37:2019 <71> Withdrawn and replaced
Sterility Tests. with newer version.
14-522..................... 14-533..................... USP 42-NF37:2019 <85> Withdrawn and replaced
Bacterial Endotoxins Test. with newer version.
14-523..................... 14-534..................... USP 42-NF37:2019 <161> Withdrawn and replaced
Medical Devices-Bacterial with newer version.
Endotoxin and Pyrogen Tests.
14-524..................... 14-535..................... USP 42-NF37:2019 <62> Withdrawn and replaced
Microbiological Examination with newer version.
of Nonsterile Products:
Tests for Specified
Microorganisms.
14-525..................... 14-536..................... USP 42-NF37:2019 <55> Withdrawn and replaced
Biological Indicators-- with newer version.
Resistance Performance Tests.
14-526..................... 14-537..................... USP 42-NF37:2019 <1229.5> Withdrawn and replaced
Biological Indicators for with newer version.
Sterilization.
----------------------------------------------------------------------------------------------------------------
S. Tissue Engineering
----------------------------------------------------------------------------------------------------------------
No new entries at this time..
----------------------------------------------------------------------------------------------------------------
\1\ All standard titles in this table conform to the style requirements of the respective organizations.
III. Listing of New Entries
In table 2, FDA provides the listing of new entries and consensus
standards added as modifications to the list of recognized standards
under Recognition List Number: 053. These entries are of standards not
previously recognized by FDA.
Table 2--New Entries to the List of Recognized Standards
------------------------------------------------------------------------
Reference No. and
Recognition No. Title of standard \1\ date
------------------------------------------------------------------------
A. Anesthesiology
------------------------------------------------------------------------
1-145.................. Lung ventilators and ISO 19223 First
related equipment-- edition 2019-07.
Vocabulary and semantics.
------------------------------------------------------------------------
B. Biocompatibility
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
C. Cardiovascular
------------------------------------------------------------------------
3-162.................. Standard Guide for Active ASTM F3374-19.
Fixation Durability of
Endovascular Prostheses.
3-163.................. Cardiovascular implants ISO 18242 First
and extracorporeal edition 2016-09-01.
systems--Centrifugal
blood pumps.
------------------------------------------------------------------------
D. Dental/Ear, Nose, and Throat (ENT)
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
E. General I (Quality Systems/Risk Management) (QS/RM)
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
F. General II (Electrical Safety/Electromagnetic Compatibility) (ES/EMC)
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
G. General Hospital/General Plastic Surgery (GH/GPS)
------------------------------------------------------------------------
6-437.................. Sharps injury protection-- ISO 23907-2 First
Requirements and test edition 2019-11.
methods--Part 2:
Reusable sharps
containers.
[[Page 17591]]
6-438.................. Medical electrical IEC 80601-2-77
equipment--Part 2-77: Edition 1.0 2019-
Particular requirements 07.
for the BASIC SAFETY and
essential performance of
ROBOTICALLY ASSISTED
SURGICAL EQUIPMENT.
------------------------------------------------------------------------
H. In Vitro Diagnostics (IVD)
------------------------------------------------------------------------
7-295.................. Verification of CLSI M52, 1st ed.
Commercial Microbial August 2015.
Identification and
Antimicrobial
Susceptibility Testing
Systems.
------------------------------------------------------------------------
I. Materials
------------------------------------------------------------------------
8-523.................. Standard Guide for Using ASTM F3275-19.
a Force Tester to
Evaluate Performance of
a Brush Part Designed to
Clean the Internal
Channel of a Medical
Device.
8-524.................. Standard Guide for Using ASTM F3276-19.
a Force Tester to
Evaluate the Performance
of a Brush Part Designed
to Clean the External
Surface of a Medical
Device.
------------------------------------------------------------------------
J. Nanotechnology
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
K. Neurology
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
L. Obstetrics-Gynecology/Gastroenterology/Urology (OB-Gyn/G/Urology)
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
M. Ophthalmic
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
N. Orthopedic
------------------------------------------------------------------------
11-361................. Implants for surgery-- ISO 14243-5 First
Wear of total knee edition 2019-05.
prostheses--Part 5:
Durability performance
of the patellofemoral
joint.
11-362................. Implants for surgery-- ISO 22622 First
Wear of total ankle- edition 2019-07.
joint prostheses--
Loading and displacement
parameters for wear-
testing machines with
load or displacement
control and
corresponding
environmental conditions
for test.
------------------------------------------------------------------------
O. Physical Medicine
------------------------------------------------------------------------
16-226................. American National ANSI/RESNA WC-4:2017
Standard for Section 10.
Wheelchairs--Volume 4:
Wheelchairs and
Transportation Section
10 Wheelchair
containment and occupant
retention systems for
use in large accessible
transit vehicles:
systems for rearward-
facing passengers.
16-227................. American National ANSI/RESNA WC-4:2017
Standard for Section 18.
Wheelchairs--Volume 4:
Wheelchairs and
Transportation Section
18: Wheelchair tiedown
and occupant restraint
systems for use in motor
vehicles.
16-228................. ANSI/RESNA W-4:2017 ANSI/RESNA WC-4:2017
American National Section 19.
Standard for
Wheelchairs--Volume 4:
Wheelchairs and
Transportation Section
19: Wheelchairs used as
seats in motor vehicles.
16-229................. American National ANSI/RESNA WC-4:2017
Standard for Section 20.
Wheelchairs--Volume 4:
Wheelchairs and
Transportation Section
20: Wheelchair seating
systems for use in motor
vehicles.
------------------------------------------------------------------------
P. Radiology
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
Q. Software/Informatics
------------------------------------------------------------------------
13-112................. Principles for medical AAMI TIR97:2019.
device security--
Postmarket risk
management for device
manufacturers.
------------------------------------------------------------------------
R. Sterility
------------------------------------------------------------------------
14-538................. Standard Guide for ASTM F3357-19.
Designing Reusable
Medical Devices for
Cleanability.
------------------------------------------------------------------------
S. Tissue Engineering
------------------------------------------------------------------------
No new entries at this
time.
------------------------------------------------------------------------
\1\ All standard titles in this table conform to the style requirements
of the respective organizations.
[[Page 17592]]
IV. List of Recognized Standards
FDA maintains the current list of FDA Recognized Consensus
Standards in a searchable database that may be accessed at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm. Such
standards are those that FDA has recognized by notice published in the
Federal Register or that FDA has decided to recognize but for which
recognition is pending (because a periodic notice has not yet appeared
in the Federal Register). FDA will announce additional modifications
and revisions to the list of recognized consensus standards, as needed,
in the Federal Register once a year, or more often if necessary.
V. Recommendation of Standards for Recognition by FDA
Any person may recommend consensus standards as candidates for
recognition under section 514 of the FD&C Act by submitting such
recommendations, with reasons for the recommendation, to
[email protected]. To be considered, such recommendations
should contain, at a minimum, the information listed on FDA's website,
which is specifically available at https://www.fda.gov/medical-devices/standards-and-conformity-assessment-program/recognition-standard.
Dated: March 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-06520 Filed 3-27-20; 8:45 am]
BILLING CODE 4164-01-P